Solid lipid microparticles: Formulation, preparation, characterisation, drug release and applications

Expert Opinion on Drug Delivery

Volumn 2, Issue 1, 2005, Pages 75-87

  Jaspart, Séverine ^a   Piel, Géraldine ^a   Delattre, Luc ^a   Evrard, Brigitte ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Administration routes; Characterisation; Drug loading; Drug release; Preparation; Solid lipid microparticles

Indexed keywords

ARGINYLLYSYLASPARTYLVALINE; CARBAMAZEPINE; CYCLODEXTRIN; DODECYL SULFATE SODIUM; DRUG CARRIER; ESTRADIOL; FENBUFEN; FLUOROURACIL; GLYCEROL BEHENATE; GONADORELIN; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; INSULIN; KETOPROFEN; LUTROL; MEDROXYPROGESTERONE ACETATE; PEPTIDE DERIVATIVE; PHOSPHATIDYLCHOLINE; PIRIBEDIL; POLOXAMER; POLYMER; POLYSORBATE 40; POLYSORBATE 80; POLYVINYL ALCOHOL; PSEUDOEPHEDRINE; SOLID LIPID MICROPARTICLE; SOLID LIPID NANOPARTICLE; TEGAFUR; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOCOMPATIBILITY; DISPERSION; DRUG ADMINISTRATION ROUTE; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; DRUG TOLERANCE; EMULSION; ENCAPSULATION; EVAPORATION; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LASER DIFFRACTION; LIPOPHILICITY; MICROSCOPY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RAMAN SPECTROMETRY; REVIEW; SCANNING ELECTRON MICROSCOPY; SOLID STATE; SPRAY DRYING; SUSTAINED RELEASE FORMULATION; X RAY DIFFRACTION;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION ROUTES; DRUG CARRIERS; EXCIPIENTS; HUMANS; LIPIDS; MICROSPHERES; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SURFACE PROPERTIES; TIME FACTORS;

EID: 12344288007     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.1.75     Document Type: Review

References (70)

1. MEHNERT W, MADER K: Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. (2001) 47:165-196.
2. ZENG XM, MARTIN GP, MARRIOTT C: The controlled delivery of drugs to the lung. Int. J. Pharm. (1995):149-164.
3. BARRATT GM: Therapeutic applications of colloidal drug carriers. Pharm. Sci. Tecchnol Today (2000) 3(5):163-171.
4. SHARMA A, SHARMA US: Liposomes in drug delivery: Progress and limitations. Int. J. Pharm. (1997) 154(2):123-140.
5. MANOSROI A, KONGKANERAMIT L, MANOSROI J: Stability and transdermal absorption of topical amphotericin B liposome formulations. Int. J. Pharm. (2004) 270(1-2):279-286.
6. BRANNON-PEPPAS L: Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharm. (1995) 116(1):1-9.
7. RAVI KUMAR MNV. Nano and microparticles as controlled drug delivery devices. J. Pharm. Pharm. Sci. (2000) 3(2 ):234-258.
8. SOPPIMATH KS, AMINABHAVI TM, KULKARNI AR et al.: Biodegradable polymeric nanoparticles as drug delivery devices. J Control. Release (2001) 70(1-2):1-20.
9. ALLEMAN E, GURNY R, DOELKER E: Drug-loaded nanoparticles - preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. (1993) 39(5):173-191.
10. REITHMEIER H, HERRMANN J, GOPFERICH A: Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int. J. Pharm. (2001) 218:133-143.
11. GUPTA PK, ADJEI AL: Modulated-release aerosol. In: Inhalation delivery of therapeutic peptides and proteins. Lung biology in health and disease. Gupta Pkadjei Al (Ed.), New York (2003):667-702.
12. DEL VALLE EMM: Cyclodextrins and their uses: a review. Process Biochemistry (2004) 39(9):1033-1046.
13. DUCHENE D, WOUESSIDJEWE D, PONCHEL G: Cyclodextrins and carrier systems. J. Control. Release (1999) 62(1-2): 263-268.
14. HU FQ, YUAN H, ZHANG HH et al.: Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int. J. Pharm. (2002) 239:121-128.
15. MULLER RH, MADER K, GOHLA S: Solid lipid nanoparticles (SLN) for controlled drug delivery- a review of the state of art. Eur. J. Pharm. Biopharm. (2000) 50:161-177.
16. SCHWARZ C, MEHNERT W: Solid lipid nanoparticles (SLN) for controlled drug delivery; drug incorporation and physicochemical characterization. J. Microencapsul. (1999) 16(2):205-213.
17. VENKATESWARLU V, MANJUNATH K: Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Release (2004) 95:627-638.
18. ZUR MUHLEN A, SCHWARZ C, MEHNERT W: Solid lipid nanoparticles (SLN) for controlled drug delivery- Drug release and release mechanism. Eur. J. Pharm. Biopharm. (1998) 45:149-155.
19. HOU D, XIE C, HUANG K et al: The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials (2003) 24(10):1781-1785.
20. SAVOLAINEN M, HERDER J, KHOO C et al.: Evaluation of polar lipid-hydrophilic polymer microparticles. Int. J. Pharm. (2003) 262(1-2):47-62.
21. PASSERINI N, PERISSUTTI B, ALBERTINI B et al.: Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing. J. Control. Release (2003) 88 2):263-275.
22. AKIYAMA Y, YOSHIOKA M, HORIBE H et al.: Novel oral controlled-release microspheres using polyglycerol esters of fatty acids. J. Control. Release (1993) 26(1):1-10.
23. RODRIGUEZ L, PASSERINI N, CAVALLARI C et al.: Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int. J. Pharm. (1999) 183 2):133-143.
24. DEL CURTO MD, CHICCO D, D'ANTONIO M et al.: Lipid microparticles as sustained release system for a GnRH antagonist (Antide). J. Control. Release (2003) 89:297-310.
25. FREDERIKSEN HK, KRISTENSEN HG, PEDERSEN M: Solid lipid microparticle formulations of the pyrethroid gamma-cyhalothrin-incompatibility of the lipid and the pyrethroid and biological properties of the formulations. J. Control. Release (2003) 86:243-252.
26. DEMIREL M, YAZAN Y, MULLER RH et al.: Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles. J. Microencapsul. (2001) 18(3):359-371.
27. SANNA V, KIRSCHVINK N, GUSTIN P et al.: Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSci Tech (2004) 5 2):Article 27.
28. ELDEM T, SPEISER P, HINCAL A: Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm. Res. (1991) 8 1):47-54.
29. BODMEIER R, WANG J, BHAGWATWAR H: Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs. J. Microencapsul. (1992) 9(1):89-98.
30. BODMEIER R, WANG J, BHAGWATWAR H: Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. II. W/O/W multiple emulsion technique for water-soluble drugs. J. Microencapsul. (1992) 9(1):99-107.
31. REITHMEIER H, HERRMANN J, GOPFERICH A: Lipid microparticles as parenteral controlled release device for peptides. J. Control. Release (2001) 73:339-350.
32. ERNI C, SUARD C, FREITAS S et al.: Evaluation of cationic sold tipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells. Biomaterials (2004) 23:4667-4676.
33. REITHMEIER H, GOPFERICH A, HERRMANN J: Preparation and characterization of lipid microparticles containing insulin. Proceedings of the 2nd World Meeting APGI/APV. Paris, France (1998) 1079.
34. MASTERS DB, DOMB AJ: Liposphere local anesthetic timed-release for perineural site application. Pharm. Res. (1998) 15(7):1038-1045.
35. BENITA S, ZOUAI O, BENOIT JP: 5-Fluorouracil: carnauba wax microspheres for chemoembloization: An in vitro evaluation. J. Pharm. Sci. US (1986) 75(9):847-851.
36. PASSERINI N, PERISSUTI B, MONEGHINI M et al.: Characterization of carbamazepine-Gelucire 50/13 microparticles prepared by a spray-congealing process using ultrasounds. J. Pharm. Sci-US (2002) 91(3):699-707.
37. YENER G, INCEGUL T, YENER N: Importance of using solid lipid microspheres as carriers for UV filters on the example octyl methoxy cinnamate. Int. J. Pharm. (2003) 258:203-207.
38. GIANNOLA LI, DI STEFANO V, DE CARO V: White beeswax microspheres: a comparative in vitro evaluation of cumulative release of the anticancer agents fluorouracil and ftorafur. Pharmazie (1993) 48(2):123-126.
39. BRASSEUR S, AMIGHI K, MOES AJ: Evaluation of solid lipid microparticles for controlled delivery to the pulmonary tract. Proceedings of the 9th Forum of Pharmaceutical Sciences. Spa, Belgium (2000) 11.
40. MALAMATARIS S, PANAGOPOULOU A, HATZIPANTOU P: Controlled release from glycerol palmito-stearate matrices prepared by dry-heat granulation and compression at elevated temperature. Drug. Dev. Ind. Pharm. (1991) 17:1765-1777.
41. SAVOLAINEN M, KHOO C, GLAD H et al.: Evaluation of controlled-release polar lipid microparticles. Int. J. Pharm. (2002) 244:151-161.
42. CORTESI R, ESPOSITO E, LUCA G et al.: Production of lipospheres as carriers for bioactive compounds. Biomaterials (2002) 23(11):2283-2294.
43. MULLER RH, MEHNERT W, LUCKS JS et al.: Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. (1995) 41 1):62-69.
44. SUGIURA S, NAKAJIMA M, TONG J et al.: Preparation of monodispersed solid lipid microspheres using a microchannel emulsification technique. J. Colloid Interf. Sci. (2000) 227 95-103.
45. KAWAKATSU T, TRAGARDH G, TRAGARDH C: Production of W/O/W emulsions and S/O/W pectin microcapsules by microchannel emulsification. Colloid Surface A (2001) 189:257-264.
46. KILLEEN MJ: Spray drying and spray congealing of pharmaceuticals. In: Encyclopedia of Pharmaceutical Technology SWARBRICK J, BOYLAN JC (Ed.) (2000):207-221.
47. BEUSELINCK L, GOVERS G, POESEN J et al.: Grain-size analysis by laser diffractometry: comparison with the sieve-pipette method. CATENA (1998) 32(3-4):193-208.
48. WASHINGTON C: Particle Size Analysis in Pharmaceutics and Other Industries: Theory and Practice. (1992) ELLIS HORWOOD.
49. WYNN EJW. HOUNSLOW MJ: Coincidence correction for electrical-zone (Coulter-counter) particle size analysers. Powder Technology (1997) 93(2):163-175.
50. MARTIN A. Micromeritics. In: Physical Pharmacy. Lippincott, Williams & Wilkins, Baltimore (2004):423-452.
51. US Pharmacopeia National Formulary (1995):1822-1823.
52. GOFFIN MEYVIS ANALYTICAL & MEDICAL SYSTEMS: Workshop on Image Analysers from Malvern Instruments (2004).
53. HICKEY AJ: Methods of aerosol particle size characterization. In: Pharmaceutical Inhalation Aerosol Technology. Drugs and the pharmaceutical sciences. HICKEY AJ (Ed.). Marcel Dekker, New York (2004):345-385.
54. US Pharmacopeia National Formulary (1995):1760-1767
55. CARLI F, GARBASSI F: Characterization of drug loading in crospovidone by X-ray photoelectron spectroscopy. J. Pharm. Sci. (1985) 74(9):963-967.
56. VOINOVICH D, MONEGHINI M, PERISSUTTI B et al.: Preparation in high-shear mixer of sustained-release pellets by melt pelletisation. Int. J. Pharm. (2000) 203(1-2):235-244.
57. WESTESEN K, BUNJES H, KOCH MHJ: Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release. J. Control. Release (1997) 48:223-23.
58. WESTESEN K, SIEKMANN B, KOCH MHJ: Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. Int. J. Pharm. (1993) 93(1-3):189-199.
59. ELDEM T, SPEISER P, ALTORFER H: Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy. Pharm. Res. (1991) 8(2):178-184.
60. MARTIN A: Micromeritics. In: Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences. Lea and Febiger, London (1993):423-449.
61. MARTIN A: Micromeritics. In: Physical Pharmacy. Lippincott, Williams & Wilkins, Baltimore (2004):30-36.
62. VITEZ IM, NEWMAN AW, DAVIDOVICH M et al.: The evolution of hot-stage microscopy to aid solid-state characterizations of pharmaceutical solids. Thermochimica Acta (1998) 324(1-2): 187-196.
63. KANEKO F, TASHIRO K, KOBAYASHI M: Polymorphic transformations during crystallization processes of fatty acids studied with FT-IR spectroscopy. J. Cryst. Growth (1999) 198-199 (Part 2): 1352-1359.
64. YAZAN Y, DEMIREL M, BUYUKKOROGLU B et al.: Solid lipid microparticle versus inclusion complex of piribedil. Proceedings of the European Conference on Drug Delivery and Pharmaceutical Technology 10-12 May, 2004. Seville, Spain (2004).
65. JASPART S, BODSON C, BERTHOLET P et al.: Solid lipid microparticles for administration by inhalation: optimisation of manufacturing parameters. Proceedings of the European Conference on Drug Delivery and Pharmaceutical Technology. 10-12 May, Seville, Spain (2004).
66. JASPART S, KIRSCHVINK N, CHIAP P et al.: Solid lipid microparticles for administration by inhalation: optimisation of manufacturing parameters and preliminary tolerance study. Proceedings 12th Forum of Pharmaceutical Sciences. 6-7 May, Blankenberge, Belgium (2004).
67. BLANCO-PRIETO MJ, BESSEGHIR K, ORSOLINI P et al.: Importance of the test medium for the release kinetics of a somatostatin analogue from poly(-lactide-co-glycolide) microspheres. Int. J. Pharm. (1999) 184(2):243-250.
68. WOO BH, KOSTANSKI JW, GEBREKIDAN S et al.: Preparation, characterization and in vivo evaluation of 120-day poly(-lactide) leuprolide microspheres. J. Control. Release (2001) 75 3):307-315.
69. OLBRICH C, MULLER RH: Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures. Int. J. Pharm. (1999) 180 1):31-39.
70. OLBRICH C, KAYSER O, MULLER RH: Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)-effect of surfactants, storage time and crystallinity. Int. J. Pharm. (2002) 237 1-2):119-128.